[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Maltaris et al., 2005 - Google Patents

Increased uterine arterial pressure and contractility of perfused swine uterus after treatment with serum from pre-eclamptic women and endothelin-1

Maltaris et al., 2005

View PDF
Document ID
3621222387961150451
Author
Maltaris T
Scalera F
Schlembach D
Hoffmann I
Mueller A
Binder H
Goecke T
Hothorn T
Schild R
Beckmann M
Dittrich R
Publication year
Publication venue
Clinical Science

External Links

Snippet

The present study was designed to examine the effects of ET-1 (endothelin-1) and serum from PE (pre-eclamptic), HP (healthy pregnant) and HNP (healthy non-pregnant) women on uterine arterial perfusion pressure and uterine contractility. Swine uteri (n= 25) were …
Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons

Similar Documents

Publication Publication Date Title
Kaplon et al. Oral trehalose supplementation improves resistance artery endothelial function in healthy middle-aged and older adults
Chapman et al. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy
Benirschke et al. The acardiac anomaly
Sholook et al. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats
Leiva et al. Cross-sectional and longitudinal lipid determination studies in pregnant women reveal an association between increased maternal LDL cholesterol concentrations and reduced human umbilical vein relaxation
Pardi et al. Human fetal growth and organ development: 50 years of discoveries
Gilbert et al. Placental and vascular adaptations to exercise training before and during pregnancy in the rat
Paauw et al. Exposure to placental ischemia impairs postpartum maternal renal and cardiac function in rats
Lemancewicz et al. Permeability of fetal membranes to calcium and magnesium: possible role in preterm labour
Maltaris et al. Increased uterine arterial pressure and contractility of perfused swine uterus after treatment with serum from pre-eclamptic women and endothelin-1
Loo et al. Lung and liver growth and retinoic acid status in human fetuses with congenital diaphragmatic hernia
Kuebler et al. Administration of progesterone after trauma and hemorrhagic shock prevents hepatocellular injury
Broberg et al. Fetal anemia leads to augmented contractile response to hypoxic stress in adulthood
Palei et al. Euglycemic hyperinsulinemia increases blood pressure in pregnant rats independent of placental antiangiogenic and inflammatory factors
Dittrich et al. The extracorporeal perfusion of swine uterus as an experimental model: the effect of oxytocic drugs
Dominguez et al. Caution should be exercised when maintaining a serum sodium level> 160 meq/L
Zabel et al. Ex vivo perfusion of the human placenta to investigate pregnancy pathologies
Boal et al. Pharmacokinetic and toxicity studies of AZT (zidovudine) following perfusion of human term placenta for 14 hours
Johnson et al. Increased fetal cell trafficking in murine lung following complete pregnancy loss from exposure to lipopolysaccharide
Sangalli et al. Carbon monoxide disposition and permeability-surface area product in the foetal circulation of the perfused term human placenta
Norkus et al. Maternal hyperglycemia and its effect on the placental transport of ascorbic acid
Caton et al. Uterine blood flow, oxygen consumption, and maternal plasma estradiol and progestins following fetal death
Lo et al. 106: novel MRI detection of impaired placental blood flow and fetal oxygen reserve in a non-human primate model of gestational protein restriction
CN117017559A (en) Rat uterine perfusion model and construction method and application thereof
Islam et al. Thyroid Dysfunction in Patient with Cirrhotic Liver Disease and its Relation to the Severity of Cirrhosis